Medimmune Sues Sun Pharma Over Plans For Ethyol Generic

Law360, New York (August 23, 2004, 12:00 AM EDT) -- Medimmune Oncology has sued Indian generic maker Sun Pharmaceuticals over its plans to make a generic version of the cancer-related drug Ethyol (amifostine).

The lawsuit, filed in U.S. District Court for the District of Maryland, accused the Indian drug maker of patent infringement and seeks a preliminary and permanent injunction barring the company from making Ethyol.

Ethyol is used as an adjunct to cancer therapy, which protects against the side effects of chemotherapy and radiation treatment. Ethyol injection is reported to reduce toxicities associated with cancer...
To view the full article, register now.